Funding Opportunities

This curated searchable database is updated on a bi-weekly basis. Contact the Office of Research and Graduate Studies if you are interested in pursuing one of these opportunities. Check the Digest Archives if you would like to see the e-mailed version of our funding opportunities. Researchers are encouraged to explore Funding Search Engines for more information.

Funding Opportunities

DeadlineFUNDING AGENCYPROGRAMAward Amount
1/15/20CPRITCOLLABORATIVE ACTION PROGRAM TO REDUCE LIVER CANCER MORTALITY IN TEXAS HIGH-IMPACT/HIGH-RISK RESEARCH AWARDS (HIHR)$250,000 - $500,000
1/15/20CANCER RESEARCH INSTITUTELLOYD J. OLD STAR PROGRAM$1.25M
1/15/20NIHIMPROVING THE REACH AND QUALITY OF CANCER CARE IN RURAL POPULATIONS (R01 CLINICAL TRIAL REQUIRED)$2.5M
1/15/20NIHTARGETING INFLAMMASOMES IN SUBSTANCE ABUSE AND HIV (R01 CLINICAL TRIAL NOT ALLOWED)NOT LIMITED
1/15/20CONTROLLED RELEASE SOCIETYFOUNDERS AWARD$5,000
1/15/20CONTROLLED RELEASE SOCIETYT. NAGAI POSTDOCTORAL RESEARCH ACHIEVEMENT AWARD$3,000
1/17/20MICHAEL J. FOX FOUNDATIONKEN GRIFFIN ALPHA-SYNUCLEIN IMAGING COMPETITION$10M
1/17/20NIHMAXIMIZING INVESTIGATORS' RESEARCH AWARD (R35 - CLINICAL TRIAL OPTIONAL)$3.75M
1/17/20ALZHEIMER'S DRUG DISCOVERY FOUNDATIONDRUG DEVELOPMENT PROGRAM$600,000
1/23/20UT AUSTINROBERT W. HAMILTON BOOK AWARDS PROGRAM$10,000
1/27/20PFIZERRHEUMATOLOGY COMPETITIVE GRANT PROGRAM$150,000
1/29/20CPRITCOMPANY RELOCATION PRODUCT DEVELOPMENT AWARDS$20M
1/29/20CPRITSEED AWARDS FOR PRODUCT DEVELOPMENT RESEARCH$3M
1/29/20CPRITTEXAS COMPANY PRODUCT DEVELOPMENT AWARDS$20M
1/31/20ST. BALDRICK'S FOUNDATIONPEDIATRIC CANCER RESEARCH GRANTS$100,000
2/5/20NIHTRANSLATIONAL BIOINFORMATICS APPROACHES TO ADVANCE DRUG REPOSITIONING AND COMBINATION THERAPY DEVELOPMENT FOR ALZHEIMER’S DISEASE (R01)$2.5M
2/5/20NIHACCELERATING THE PACE OF DRUG ABUSE RESEARCH USING EXISTING DATA (R01 CLINICAL TRIAL OPTIONAL)$2.5M
2/5/20NIHOMICS-GUIDED BIOBEHAVIORAL INTERVENTIONS FOR IMPROVED HEALTH OUTCOMES: A STEP FORWARD IN TRANSLATION (R01 CLINICAL TRIAL OPTIONAL)NOT LIMITED
2/7/20ATSBEAR CAGE (BUILDING EDUCATION TO ADVANCE RESEARCH) COMPETITION$10,000
2/10/20NIHNIMH INSTRUMENTATION PROGRAM (S10 CLINICAL TRIAL NOT ALLOWED)$600,000
2/12/20CPRITEVIDENCE-BASED CANCER PREVENTION SERVICES$1M
2/12/20CPRITEXPANSION OF CANCER PREVENTION SERVICES TO RURAL AND MEDICALLY UNDERSERVED POPULATIONS$2M
2/12/20NIHNIAID CAREER TRANSITION AWARD (K22 INDEPENDENT CLINICAL TRIAL NOT ALLOWED)SALARY AND PROGRAM-RELATED EXPENSES
2/16/20NIHSAFETY AND OUTCOME MEASURES OF PAIN MEDICATIONS USED IN CHILDREN AND PREGNANT WOMEN (R03 CLINICAL TRIAL OPTIONAL)$100,000
2/19/20NIHNEW APPROACHES FOR INCORPORATING GENETIC DIVERSITY INTO TOXICITY TESTING (R43/R44 CLINICAL TRIAL NOT ALLOWED)$252,131
2/21/20NIHINNOVATIVE MOLECULAR AND CELLULAR ANALYSIS TECHNOLOGIES FOR BASIC AND CLINICAL CANCER RESEARCH (R21 CLINICAL TRIALS NOT ALLOWED)$400,000
2/22/20AFPEGATEWAY TO RESEARCH SCHOLARSHIPS$5,000
2/24/20NIHEFFECTIVENESS OF IMPLEMENTING SUSTAINABLE EVIDENCE-BASED MENTAL HEALTH PRACTICES IN LOW-RESOURCE SETTINGS TO ACHIEVE MENTAL HEALTH EQUITY FOR TRADITIONALLY UNDERSERVED POPULATIONS (R01 CLINICAL TRIAL OPTIONAL)NOT LIMITED
2/26/20NIHNCI PATHWAY TO INDEPENDENCE AWARD FOR OUTSTANDING EARLY STAGE POSTDOCTORAL RESEARCHERS (K99/R00 - INDEPENDENT CLINICAL TRIAL NOT ALLOWED)SEE ANNOUNCEMENT
ROLLINGTHRASHER RESEARCH FUNDE.W. "AL" THRASHER AWARDNOT LIMITED
ROLLINGA KIDS' BRAIN TUMOR CURELOI FOR PLGA TUMOR RESEARCH$100,000 - $500,000
ROLLINGHOGG FOUNDATION FOR MENTAL HEALTHFRANCES FOWLER WALLACE MEMORIAL AWARD FOR MENTAL HEALTH DISSERTATION RESEARCH$1,500
ROLLING (LOI)ROBERT WOOD JOHNSON FOUNDATIONEVIDENCE FOR ACTION: INVESTIGATOR-INITIATED RESEARCH TO BUILD A CULTURE OF HEALTHNOT LIMITED
ROLLING (LOI)PARKINSON’S FOUNDATIONIMPACT AWARD$150,000
ROLLINGNIHSTRATEGIC ALLIANCES FOR MEDICATIONS DEVELOPMENT TO TREAT SUBSTANCE USE DISORDERS (R01CLINICAL TRIAL OPTIONAL)$9M
SEE ANNOUNCEMENTNIHADMINISTRATIVE SUPPLEMENT TO EXISTING NIH GRANTS AND COOPERATIVE AGREEMENTS (PARENT ADMIN SUPP CLINICAL TRIAL OPTIONAL)SEE ANNOUNCEMENT
SEE ANNOUNCEMENTNIHRESEARCH SUPPLEMENTS TO PROMOTE DIVERSITY IN HEALTH-RELATED RESEARCH (ADMIN SUPP - CLINICAL TRIAL NOT ALLOWED)SEE ANNOUNCEMENT

*Limited submission programs are those for which funding agencies restrict the number of nominations or proposals a university may submit for consideration for an award. The University of Texas at Austin must internally screen all eligible and interested nominees to determine which will represent the university in the regional, national or international competitions. For more information, please visit UT Austin Office of the Vice President for Research-Limited Submission Programs.